Proteins C and S in patients with advanced prostatic cancer.
Oliveira
P D
PD
Centro de Fisiologia da Hemóstase (INIC), Dpt. of Physiology, Oporto Medical School, Porto, Portugal.
Oliveira
M G
MG
Pina
F
F
Andrade
J A
JA
Pina-Cabral
J M
JM
D002064:Buserelin / Q000627:therapeutic use; D002352:Carrier Proteins / Q000097:blood; D015935:Complement C4b / Q000378:metabolism; D003169:Complement Inactivator Proteins; D005485:Flutamide / Q000627:therapeutic use; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D011486:Protein C / Q000378:metabolism*; D017293:Protein S
D002352:Carrier Proteins; D003169:Complement Inactivator Proteins; D006023:Glycoproteins; D011486:Protein C; D017293:Protein S; D005485:Flutamide; D015935:Complement C4b; D002064:Buserelin